Upgrade to SI Premium - Free Trial

Maxim Group Resumes MediciNova (MNOV) at Buy, PT $6

March 23, 2026 7:27 AM
Maxim Group analyst Jason McCarthy resumes coverage on MediciNova (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Hot New Coverage New Coverage